• Profile
Close

Double-blind placebo-controlled randomized clinical trial of neurofeedback for attention-deficit/hyperactivity disorder with 13 month follow-up

Journal of the American Academy of Child & Adolescent Psychiatry Sep 07, 2020

Eugene Arnold L, Arns M, Barterian J, et al. - This 2-site double-blind randomized clinical trial was undertaken to determine if theta/beta-ratio (TBR) electroencephalographic biofeedback (neurofeedback, NF) has a specific impact on attention-deficit/hyperactivity disorder (ADHD) beyond nonspecific benefit. One hundred forty-four children, aged 7 to 10 years, with rigorously diagnosed moderate/severe ADHD and theta/beta-ratio (TBR) > 4.5 were randomized 3:2 to deliberate TBR downtraining vs a control of equal duration, intensity, and appearance. According to the results, blinding was great. This research does not support a clear impact of deliberate TBR NF at either treatment end or 13-month follow-up. Participants are to be reassessed at a follow-up of 25 months.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay